Neuraxis Inc. (NYSE AMERICAN: NRXS) Stock Information | RedChip

Neuraxis Inc. (NYSE AMERICAN: NRXS) Listen to this Section


$3.14
+0.0050 ( +0.16% ) 1.8K

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Market Data


Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 70 May 20, 2024
nt Quarterly Reports 1 May 15, 2024
8-k 8K-related 14 Apr 16, 2024
10-k Annual reports 114 Apr 16, 2024
8-k 8K-related 14 Apr 09, 2024
nt Quarterly Reports 1 Apr 01, 2024
8-k 8K-related 15 Mar 28, 2024
3 Insider transactions 1 Mar 15, 2024
8-k 8K-related 44 Mar 11, 2024
4 Insider transactions 1 Feb 29, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.